LARS1 and pancreatic adenocarcinoma: In contrast, LARS1, NARS1, QARS1, and LARS2 are significantly underexpressed in acute myeloid leukemia, pancreatic adenocarcinoma, squamous cell lung carcinoma, and clear cell renal cell carcinoma, respectively.